Dupixent: Drug Overview & Outlook 2017-2018 to 2026 - ResearchAndMarkets.com

DUBLIN--()--The "Drug Overview: Dupixent" report has been added to ResearchAndMarkets.com's offering.

Dupixent (dupilumab; Regeneron/Sanofi) is an injectable monoclonal antibody directed against the interleukin (IL)-4 receptor alpha subunit, which blocks signaling from both IL-4 and IL-13. This is a novel mechanism of action for the treatment of severe asthma, with the majority of marketed biologics targeting IL-5.

Key Topics Covered

  1. Product Profiles
  2. Dupixent: Asthma
  3. Dupixent: Atopic Dermatitis

List of Figures

Figure 53: Trelegy Ellipta for asthma - SWOT analysis

Figure 54: Drug assessment summary of Trelegy Ellipta in asthma

Figure 55: Drug assessment summary of Trelegy Ellipta in asthma

Figure 56: Trelegy Ellipta sales for asthma across the US, Japan, and five major EU markets, by country, 2017-26

Figure 56: Xolair for asthma - SWOT analysis

Figure 6: Drug assessment summary of Dupixent in atopic dermatitis

Figure 7: Drug assessment summary of Dupixent in atopic dermatitis

List of Tables

Table 1: Dupixent drug profile

Table 2: Dupixent Phase III data in asthma

Table 3: Dupixent Phase III trials in asthma

Table 4: Dupixent sales for asthma across the US, Japan, and five major EU markets, by country ($m), 2017-26

Table 5: Dupixent drug profile

Table 50: Trelegy Ellipta sales for asthma across the US, Japan, and five major EU markets, by country ($m), 2017-26

For more information about this report visit https://www.researchandmarkets.com/research/mkd7hk/dupixent_drug?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Dermatological Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Dermatological Drugs